2017
DOI: 10.1111/jdv.14224
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and incidence of hidradenitis suppurativa: an exercise on indirect estimation from psoriasis data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 9 publications
0
9
0
2
Order By: Relevance
“…Also, most experts concur that the maximum duration of the active form of HS in a given patient is about 20 years [6]. With regard to the estimated prevalence of the disease in European countries and in the United States, available data differ by up to four orders of magnitude, ranging from 0.00033% to 4.1% [7][8][9][10][11][12][13][14][15][16][17][18].…”
Section: Situation In the Usa And Europementioning
confidence: 99%
See 2 more Smart Citations
“…Also, most experts concur that the maximum duration of the active form of HS in a given patient is about 20 years [6]. With regard to the estimated prevalence of the disease in European countries and in the United States, available data differ by up to four orders of magnitude, ranging from 0.00033% to 4.1% [7][8][9][10][11][12][13][14][15][16][17][18].…”
Section: Situation In the Usa And Europementioning
confidence: 99%
“…Więk-szość ekspertów jest również zgodna, że czas trwania czynnej postaci HS wynosi u danego pacjenta maksymalnie ok. 20 lat [6]. Dane dotyczące częstości wystę-powania choroby w krajach europejskich i USA różnią się nawet o 4 rzędy wielkości i mieszczą się w przedziale od 0,00033% do 4,1% [7][8][9][10][11][12][13][14][15][16][17][18].…”
Section: Sytuacja W Usa I Europieunclassified
See 1 more Smart Citation
“…HS is a chronic, inflammatory, debilitating disease with a relapsing nature, characterized by painful inflammatory nodules, abscesses, and fistulas predominantly affecting intertriginous sites, including axillae, breasts, groin, buttocks, and perineum [12]. The prevalence of HS is unknown: estimates range from <0.1% [13] to over 4% [14] of the general population. The pathogenesis of HS is multifactorial and not fully understood [15].…”
Section: Introductionmentioning
confidence: 99%
“…First, its prevalence is still uncertain. It has been estimated to occur in a range from less than 0.1 [2-4] up to 2 [5], 4 [6], or even 8% [7]. Also, patients with HS have been treated by many different medical specialties, but by none of them in particular.…”
Section: Introductionmentioning
confidence: 99%